摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-氯-2-甲氧基苯硼酸 | 179898-50-1

中文名称
3-氯-2-甲氧基苯硼酸
中文别名
——
英文名称
(3-chloro-2-methoxyphenyl)boronic acid
英文别名
——
3-氯-2-甲氧基苯硼酸化学式
CAS
179898-50-1
化学式
C7H8BClO3
mdl
MFCD08277278
分子量
186.403
InChiKey
VHQABGUEHFRBRI-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    356.9±52.0 °C(Predicted)
  • 密度:
    1.32±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.91
  • 重原子数:
    12
  • 可旋转键数:
    2
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.142
  • 拓扑面积:
    49.7
  • 氢给体数:
    2
  • 氢受体数:
    3

安全信息

  • 危险性防范说明:
    P280,P305+P351+P338
  • 危险性描述:
    H302

SDS

SDS:7fa566453cbf6fe96a228c30c56ab689
查看
Material Safety Data Sheet

Section 1. Identification of the substance
Product Name: 3-Chloro-2-methoxyphenylboronic acid
Synonyms:

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

Section 3. Composition/information on ingredients.
Ingredient name: 3-Chloro-2-methoxyphenylboronic acid
CAS number: 179898-50-1

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C7H8BClO3
Molecular weight: 186.4

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, hydrogen chloride.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
Non-harzardous for air and ground transportation.

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    3-氯-2-甲氧基苯硼酸四(三苯基膦)钯potassium acetate 、 palladium diacetate 、 三溴化硼 、 sodium carbonate 、 potassium carbonate2-二环己基磷-2,4,6-三异丙基联苯 作用下, 以 1,4-二氧六环乙醇二氯甲烷N,N-二甲基甲酰胺 为溶剂, 反应 72.0h, 生成
    参考文献:
    名称:
    ORGANIC LIGHT-EMITTING MATERIALS CONTAINING CYANO-SUBSTITUTED LIGAND
    摘要:
    揭示了一种含有氰基取代配体的有机发光材料。这种有机发光材料是一种含有氰基取代配体的金属配合物,可用作有机电致发光器件的发光层中的发光材料。这些新的配合物可以提供更好的器件性能,例如更窄的半峰全宽、更低的电压值和更高的量子效率等。还公开了一种电致发光器件和含有金属配合物的化合物配方,以及一种可用于制备金属配合物的化合物。
    公开号:
    US20200251666A1
  • 作为产物:
    描述:
    2-溴-6-氯苯甲醚硼酸三甲酯正丁基锂 作用下, 以 5-氟-2-甲氧基苯硼酸 为溶剂, 以0.55 g (91%)的产率得到3-氯-2-甲氧基苯硼酸
    参考文献:
    名称:
    Steroid receptor modulator compounds and methods
    摘要:
    披露了对类固醇受体具有高亲和力、高选择性调节剂的非类固醇化合物。还披露了包含这些化合物的药物组合物、使用所披露的化合物和组合物治疗需要类固醇受体激动剂或拮抗剂治疗的患者的方法,以及在制备这些化合物中有用的中间体和制备类固醇受体调节剂化合物的过程。
    公开号:
    US05688810A1
点击查看最新优质反应信息

文献信息

  • [EN] TETRAZOLINONE COMPOUNDS AND ITS USE AS PESTICIDES<br/>[FR] COMPOSÉS DE TÉTRAZOLINONE ET LEUR UTILISATION EN TANT QUE PESTICIDES
    申请人:SUMITOMO CHEMICAL CO
    公开号:WO2013162072A1
    公开(公告)日:2013-10-31
    The present invention provides a compound having an excellent efficacy for controlling pests. A tetrazolinone compound of a formula (1): [wherein R1 represents an C6-C16 aryl group, an C1-C12 alkyl group, or a C3-C12 cycloalkyl group, etc., which each optionally be substituted; R2, R3, R4 and R5 represent independently of each other a hydrogen atom, a halogen atom or an C1-C3 alkyl group, etc.; R6 represents an C1-C6 alkyl group, a C3-C6 cycloalkyl group, a halogen atom, a C1-C6 haloalkyl group, an C2-C6 alkenyl group, an C1-C6 alkoxy group, or a C1-C6 haloalkoxy group, etc.; R7, R8 and R9 represent independently of each other a hydrogen atom, a halogen atom, or an C1-C4 alkyl group, etc.; X represents an oxygen atom or a sulfur atom; and R10 represents an C1-C6 alkyl group, etc.] shows an excellent controlling efficacy on pests.
    本发明提供了一种具有优异杀虫效果的化合物。公式(1)的四唑酮化合物:[其中R1代表C6-C16芳基、C1-C12烷基或C3-C12环烷基等,每个都可以选择性地被取代;R2、R3、R4和R5分别独立地代表氢原子、卤素原子或C1-C3烷基等;R6代表C1-C6烷基、C3-C6环烷基、卤素原子、C1-C6卤代烷基、C2-C6烯基、C1-C6烷氧基或C1-C6卤代烷氧基等;R7、R8和R9分别独立地代表氢原子、卤素原子或C1-C4烷基等;X代表氧原子或硫原子;R10代表C1-C6烷基等]在杀虫方面表现出优异的控制效果。
  • 신규한 헤테로고리 화합물 및 이를 포함하는 유기발광 소자
    申请人:LG CHEM, LTD. 주식회사 엘지화학(120010134563) Corp. No ▼ 110111-2207995BRN ▼107-81-98139
    公开号:KR20180010165A
    公开(公告)日:2018-01-30
    본 발명은 신규한 헤테로고리 화합물 및 이를 포함하는 유기발광 소자를 제공한다.
    这项发明提供了一种新型的杂环化合物以及包含该化合物的有机发光器件。
  • 화합물 및 이를 포함하는 유기 발광 소자
    申请人:LG CHEM, LTD. 주식회사 엘지화학(120010134563) Corp. No ▼ 110111-2207995BRN ▼107-81-98139
    公开号:KR20200038876A
    公开(公告)日:2020-04-14
    본 명세서는 화학식 1의 화합물 및 이를 포함한 유기 발광 소자를 제공한다.
    这份规范提供了化学式1的化合物以及包含该化合物的有机发光器件。
  • [EN] SMARCA INHIBITORS AND USES THEREOF<br/>[FR] INHIBITEURS DE SMARCA ET LEURS UTILISATIONS
    申请人:KYMERA THERAPEUTICS INC
    公开号:WO2020251974A1
    公开(公告)日:2020-12-17
    The present invention provides compounds, pharmaceutically acceptable compositions thereof, and methods of using the same for the modulation of one or more SWI/SNF-related matrix associated actin dependent regulator of chromatin subfamily A (SMARCA) and/or polybromo-1 (PB-1) protein via ubiqitination and/or degradation by compounds. The compounds are useful in treatment of cancer.
    本发明提供了化合物、其药用可接受的组合物,以及使用这些化合物调节一个或多个SWI/SNF相关基质相关肌动蛋白依赖调节剂基因座亚家族A(SMARCA)和/或polybromo-1(PB-1)蛋白通过化合物的泛素化和/或降解的方法。这些化合物在癌症治疗中很有用。
  • [EN] KRAS G12D INHIBITORS<br/>[FR] INHIBITEURS DE KRAS G12D
    申请人:MIRATI THERAPEUTICS INC
    公开号:WO2021041671A1
    公开(公告)日:2021-03-04
    The present invention relates to compounds that inhibit KRas G12D. In particular, the present invention relates to compounds that inhibit the activity of KRas G12D, pharmaceutical compositions comprising the compounds and methods of use therefor.
    本发明涉及抑制KRas G12D的化合物。具体地,本发明涉及抑制KRas G12D活性的化合物,包括这些化合物的药物组合物以及使用方法。
查看更多